Look on Archives

PubMed
nih-central pmc-central

Articles

Open Access Article
Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant
David J. Riese II
1,187+ Views
206 Citations
Open Access Article
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole
CP Coyne
1,475+ Views
134 Citations
Open Access Article
Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice
Srinivasa T. Reddy, Robin Farias-Eisner
1,496+ Views
112 Citations
Open Access Article
Pharmacological Effects of Selected Medicinal Plants and Vitamins Against COVID-19
Clement G Yedjou
2,312+ Views
273 Citations
Open Access Article
Immunomodulatory Response Triggered by the Alkaloids, 3-Amino- 7-Benzylbenzimidazo[3,2-a] Quinolinium Chloride (ABQ-48) and 3-Nitro- 7-Benzylbenzimidazo[3,2-a] Quinolinium Chloride (NBQ-48)
Beatriz Zayas
2,465+ Views
175 Citations
Open Access Article
The Cox-2 Inhibitor Meloxicam Ameliorates Neuroinflammation and Depressive Behavior in Adult Mice after Splenectomy
Thomas Wisniewski
2,398+ Views
242 Citations

Multinational Editorial Team

Editorial Excellence

icon

Publish Your Research Work in Esteemed Journals

Mohamed Kamal Motawi

Mohamed Kamal Motawi

Professor
Cairo University
Egypt
View Biography βž”
Azza Mahmoud Kamel

Azza Mahmoud Kamel

Emeritus Professor of Clinical Pathology
National Cancer Institute
Egypt
View Biography βž”
Rajesh Pasricha

Rajesh Pasricha

Professor and Head
Department of Radiotherapy
All India Institute of Medical Sciences Bhopal
India
View Biography βž”
Seyed Mohammad Akrami

Seyed Mohammad Akrami

Assistant professor
Endocrine and Metabolism Research Center (EMRC)
Tehran University of Medical Sciences (TUMS...
View Biography βž”
Dr. Shraddha Vyas

Dr. Shraddha Vyas

Research Investigator in Baylor Scott and White Research Institute Dallas, TX U.S.A View Biography βž”
Karchugina Sofiia Arkadyevna

Karchugina Sofiia Arkadyevna

Fox Chase Cancer Center
Philadelphia
United States
View Biography βž”
Xiaodong Li

Xiaodong Li

Associate Chief Physician
Department of Oncology
The First PeopleÒ€ℒs Hospital of Changzhou
China
View Biography βž”
Juan Wang

Juan Wang

Physician
Department of Medical Oncology
Hospital of Zhejiang University School of Medicine
China
View Biography βž”
Salma Lafyan Alsulami

Salma Lafyan Alsulami

Internal medicine Resident
Medical Cities of Ministry of Interior
Saudi Arabia
View Biography βž”
Dongxi Xiang

Dongxi Xiang

Brigham and Womens Hospital
Harvard Medical School
USA
View Biography βž”
Zhi-Ling YU

Zhi-Ling YU

Professor
Hong Kong Baptist University
China
View Biography βž”
Mohd Amin Mir

Mohd Amin Mir

Head of Clinical Research Division
Venus Remedies Ltd
India
View Biography βž”
Ying Chen

Ying Chen

Visiting Assistant Professor
Purdue University
U.S.A
View Biography βž”
Zafar Rasheed

Zafar Rasheed

Assistant Professor
Department of Medical Biochemistry, College of Medicine
Qassim University
Saudi A...
View Biography βž”
Mustafa Metin Donma

Mustafa Metin Donma

Professor
Namik Kemal University
Turkey
View Biography βž”
Ziad El Ali

Ziad El Ali

Head of the Department of Medical Oncology
IRIS-Sud Hospitals- Brussels
Belgium
View Biography βž”
Shijie Sheng

Shijie Sheng

Professor of Pathology and Oncology
Wayne State University School of Medicine
U.S.A
View Biography βž”
Prieto-Nieto MI

Prieto-Nieto MI

Peritoneal Oncological Surgery Unit
Hospital La Paz
Spain
View Biography βž”
 Josep M. Argilés

Josep M. Argilés

Professor
Biochemistry and Molecular Biology of Cancer
University of Barcelona
Spain
View Biography βž”
Hironobu Ihn

Hironobu Ihn

Vice President
Kumamoto University Hospital
Japan
View Biography βž”

Journal Metrics

icon ISSN: 2770-4211
icon Crossref: Registered
βœ” Peer Review: Double Blind
icon DOI: Available
Β© Copyright: Creative Commons Attribution 4.0
icon Language: English
google

Author's Feedback

(What authors say about publishing with us)

Most Cited Articles

Multi-Modal Assessment of LI-RADS 3 and 4 Lesions: Integrating Serum Biomarkers, Liquid Biopsy, and Imaging for Early Hepatocellular Carcinoma Detection and Management

Alexandre Tavartkiladze

DOI: 10.17303/jocr.2025.6.103

article image

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths, often linked to chronic liver disease or cirrhosis. ...

456 Views

186 Downloads

Management of the Axilla in Breast Cancer Surgery

Andreas C. Sidiropoulos

DOI: 10.17303/jocr.2024.5.102

article image

We summarize important clinical advances that have led us to today's surgical management of breast cancer and pave the way to new levels of de-escalation in breast cancer surgery....

327 Views

190 Downloads

The Role of NCOA4 in Glioma Progression and TMZ Sensitivity

Jia Zhifan , Tong Xiaoguang

DOI: 10.17303/jocr.2024.5.105

article image

We identified the NCOA4 expression in glioma cells and glioma specimens by Western blot (WB). Overexpression NCOA4 glioma cell lines were induced by recombinant adenovirus of NCOA4...

67 Views

85 Downloads

Development and Validation of Nomogram for Predicting Upper Limb Lymphedema and Shoulder Joint Dysfunction Following Postoperative Radiotherapy in Breast Cancer

Quanqing Zou, Jian Qin

DOI: 10.17303/jocr.2025.6.101

article image

Upper Limb Lymphedema (ULL) and Shoulder Joint Dysfunction (SJD) are common sequelae following breast cancer (BC) treatment, though their underlying pathophysiological...

291 Views

77 Downloads

Early Biomarkers of Malignant Tumor Initiation and Progression: A Comprehensive Review

Alexandre Tavartkiladze

DOI: 10.17303/jocr.2024.5.103

article image

Early detection and accurate monitoring of malignant tumors are crucial for effective treatment and improved patient outcomes. This review examines a comprehensive array of biomark...

373 Views

133 Downloads

Phase I Study of Lurbinectedin in Japanese Patients with Pretreated Advanced Solid Tumors

Shunji Takahashi

DOI: 10.17303/jocr.2025.6.102

article image

In this phase I trial, Japanese patients with unresectable/advanced solid tumors were treated at 1.5, 2.5 and 3.2 mg/m2 q3wk without primary granulocyte colony-stimulating factor (...

422 Views

175 Downloads